fusarium has been researched along with Entomophthoramycosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, E; Geffen, Y; Hardak, E; Oren, I; Zuckerman, T | 1 |
| Fang, X; Geng, S; Li, Y; Wang, Y; Yang, X; Zhou, X | 1 |
| Nucci, M | 1 |
| Al-Abdely, HM | 1 |
| Perfect, JR | 1 |
| Kauffman, CA; Malani, AN | 1 |
| Chanock, SJ; Walsh, TJ | 1 |
| Hirai, H; Hori, A; Kami, M; Kanda, Y; Kashima, T; Machida, U; Matsumura, T; Mori Si, S; Mutou, Y; Okuzumi, K; Sakamaki, H; Takaue, Y; Yoneyama, A | 1 |
4 review(s) available for fusarium and Entomophthoramycosis
| Article | Year |
|---|---|
Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients.
Topics: Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycetoma; Mycoses; Organ Transplantation; Prognosis; Scedosporium; Zygomycosis | 2003 |
Management of rare fungal infections.
Topics: Antifungal Agents; Fusarium; Humans; Mycoses; Penicillium; Scedosporium; Zygomycosis | 2004 |
Changing epidemiology of rare mould infections: implications for therapy.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis | 2007 |
Diagnosis of invasive fungal infections: advances in nonculture systems.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Candida; Candidiasis; Coccidioidomycosis; Cryptococcosis; DNA, Fungal; Fungemia; Fusarium; Histoplasmosis; Humans; Immunoassay; Microbial Sensitivity Tests; Mycoses; Polymerase Chain Reaction; Pseudallescheria; Trichosporon; Zygomycosis | 1998 |
4 other study(ies) available for fusarium and Entomophthoramycosis
| Article | Year |
|---|---|
Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Fungi; Fusarium; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Tertiary Care Centers; Young Adult; Zygomycosis | 2020 |
Pathogenicity of Conidiobolus coronatus and Fusarium solani in mouse models.
Topics: Animals; Conidiobolus; Cyclophosphamide; Disease Models, Animal; Fusariosis; Fusarium; Immunocompromised Host; Immunosuppressive Agents; Lung; Male; Mice; Mice, Inbred ICR; Prednisolone; Skin; Zygomycosis | 2017 |
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Fusarium; Humans; Immunocompromised Host; Infant; Kidney; Male; Middle Aged; Mycoses; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Retrospective Studies; Treatment Outcome; Zygomycosis | 2005 |
Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Autopsy; Candidiasis; Cryptococcosis; Female; Fluconazole; Fungi; Fusarium; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycology; Mycoses; Predictive Value of Tests; Regression Analysis; Sensitivity and Specificity; Trichosporon; Zygomycosis | 2002 |